|
Bay Area Tumor Institute CCOP
|
5U10CA045461-21
|
$461,201
|
$4,612
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Improving T-cell therapies for neuroblastoma
|
1R01CA142636-01
|
$280,644
|
$280,644
|
DOTTI, GIANPIETRO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-04
|
$3,089,219
|
$30,892
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S6
|
$100,000
|
$1,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-04S1
|
$250,400
|
$2,504
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Plasminogen activator inhibitor-1 in tumor progression and metastasis
|
5R01CA129377-03
|
$239,794
|
$239,794
|
DeClerck, Yves
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Gene Expression of Neuroblastoma and Normal Cells in Bone Marrow Predicts Outcome
|
1R33CA152809-01
|
$441,722
|
$441,722
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Biology and Therapy of High Risk Neuroblastoma
|
2P01CA081403-11
|
$2,135,965
|
$2,135,965
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Clinical Correlative Studies of Neuroblastoma
|
5R01CA060104-17
|
$428,770
|
$428,770
|
SEEGER, ROBERT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Targeting Oncolytic HSV to Neuroblastoma & Malig. Peripheral Nerve Sheath Tumors
|
5F31CA132613-03
|
$33,913
|
$16,957
|
Maldonado, Arturo
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Discovery of Chromosome Arm 11q Tumor Suppressor Genes in Neuroblastoma
|
5K08CA123100-05
|
$139,320
|
$139,320
|
ATTIYEH, EDWARD
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Molecular Genetic Analysis of Human Neuroblastoma
|
5R01CA039771-22
|
$388,815
|
$388,815
|
BRODEUR, GARRETT
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Trk Expression and Inhibition in Human Neuroblastomas
|
5R01CA094194-08
|
$387,333
|
$387,333
|
BRODEUR, GARRETT
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Translational Genomics of MicroRNAs in Neuroblastoma
|
5K08CA136979-02
|
$158,005
|
$158,005
|
Cole, Kristina
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Copy number variations (CNVs) in neuroblastoma
|
1K99CA151869-01
|
$170,826
|
$170,826
|
Diskin, Sharon
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
5R01CA124709-03
|
$667,730
|
$667,730
|
MARIS, JOHN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Targeting Oncogenic ALK Signaling in Neuroblastoma
|
5R01CA140198-02
|
$343,973
|
$343,973
|
Mosse, YAEL
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-24
|
$1,202,700
|
$12,027
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Cancer Center Support Grant
|
3P30CA013696-37S1
|
$100,000
|
$2,000
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-37
|
$4,017,288
|
$80,346
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
VEGF blockade and alternative angiogenic pathways in neuroblastoma
|
3R01CA124644-03S1
|
$132,377
|
$132,377
|
YAMASHIRO, DARRELL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
VEGF blockade and alternative angiogenic pathways in neuroblastoma
|
5R01CA124644-03
|
$334,075
|
$334,075
|
YAMASHIRO, DARRELL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
"Oncorequisite" Genes in MYC-mediated Transformation
|
5K99CA134743-02
|
$140,940
|
$28,188
|
Feng, Hui
|
DANA-FARBER CANCER INSTITUTE
|
|
Duluth Community Clinical Oncology Program
|
2U10CA035269-27
|
$727,154
|
$7,272
|
NIKCEVICH, DANIEL
|
DULUTH CLINIC, LTD.
|
|
Optimizing Pro-Apoptotic Therapeutics With Kinase Inhibition in Neuroblastoma
|
5K08CA128925-04
|
$139,320
|
$139,320
|
Goldsmith, Kelly
|
EMORY UNIVERSITY
|
|
MDM2 regulates XIAP gene expression in cancer treatment
|
5R01CA123490-03
|
$257,300
|
$64,325
|
ZHOU, MUXIANG
|
EMORY UNIVERSITY
|
|
EORTC DATA CENTER
|
5U10CA011488-40
|
$422,853
|
$8,457
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Community Clinical Oncology Program: FL Pediatric CCOP
|
2U10CA035157-27
|
$390,002
|
$15,600
|
TALBERT, JAMES
|
FLORIDA ASSN OF PEDIATRIC TUMOR PROG
|
|
Neuropeptide Y in neuroblastoma: growth, angiogenesis and future therapeutics.
|
5R01CA123211-05
|
$267,492
|
$267,492
|
KITLINSKA, JOANNA
|
GEORGETOWN UNIVERSITY
|
|
Georgetown University, Lombardi Cancer Center Support Grant Competitive Renewal
|
2P30CA051008-17
|
$1,627,433
|
$32,549
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Georgetown University, Lombardi Cancer Center Support Grant Competitive Renewal
|
3P30CA051008-17S2
|
$99,414
|
$1,988
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Georgetown University, Lombardi Cancer Center Support Grant Competitive Renewal
|
3P30CA051008-17S3
|
$153,445
|
$3,069
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Iowa Oncology Research Association
|
5U10CA035101-25
|
$685,544
|
$6,855
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
Tumor-produced TNF alpha as an inducer of immune resistance and tumor survival
|
1R01CA136663-01A2
|
$340,300
|
$340,300
|
Levitskaia, Elena
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-48S1
|
$100,000
|
$1,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-48S2
|
$47,307
|
$473
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-48
|
$7,708,192
|
$77,082
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
LSUHSC Minority-Based Community Clinical Oncology Program
|
5U10CA063845-12
|
$468,642
|
$4,686
|
VEITH, ROBERT
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
Marshfield Community Clinical Oncology Program
|
5U10CA035412-27
|
$946,378
|
$9,464
|
Weiss, Matthias
|
MARSHFIELD CLINIC RESEARCH FOUNDATION
|
|
Simultaneous Tc-99m-MDP/I-123-MIBG Imaging of Neuroblastoma Using SPECT-CT
|
1R21CA140771-01A1
|
$230,985
|
$230,985
|
Ouyang, Jinsong
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Cancer Center Support (Core) Grant
|
2P30CA014051-39
|
$4,057,188
|
$40,572
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Chemistry and Biology of Platinum Anticancer Drugs
|
5R01CA034992-28
|
$703,653
|
$140,731
|
Lippard, Stephen
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
The oncogenic basis of Bmi-1 in neuroblastoma development
|
5R01CA124982-04
|
$279,300
|
$279,300
|
DING, HAN-FEI
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
MCG Minority-Based Community Clinical Oncology Program
|
3U10CA107586-07S1
|
$100,784
|
$1,008
|
Jillella, Anand
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
MCG Minority-Based Community Clinical Oncology Program
|
5U10CA107586-07
|
$509,490
|
$5,095
|
Jillella, Anand
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
Optimizing Immunotherapy for Neuroblastoma after BMT
|
5R01CA100030-07
|
$304,318
|
$304,318
|
JOHNSON, BRYON
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Research Management and Support
|
RMS2010 [E]
|
$345,370,533
|
$24,000
|
N/A
|
National Cancer Institute
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-08
|
$26,966,030
|
$1,887,622
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
3U10CA098413-08S1
|
$1,499,003
|
$104,930
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center Grant
|
3U10CA098413-08S2
|
$39,636
|
$2,775
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
Total relevant funding to Neuroblastoma for this search: $20,050,819
|